Literature DB >> 11458116

Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate.

B Planz1, Q Wang, S D Kirley, M Marberger, W S McDougal.   

Abstract

PURPOSE: Stromal-epithelial interactions of growth factors and the androgen receptor may have implications for the pathophysiology of benign and neoplastic transformation of the human adult prostate. We investigated a possible interaction of keratinocyte growth factor with its receptor as well as with the androgen receptor signaling pathway in human prostatic epithelial cells.
MATERIALS AND METHODS: Human prostatic epithelial cells were obtained from explant primary culture, established in DU145 cell conditioned medium and maintained in keratinocyte serum-free medium with supplements. Epithelial cells were characterized by light and electron microscopy, and immunocytochemical study using epithelial and mesenchymal markers. Androgen receptor, keratinocyte growth factor receptor and keratinocyte growth factor messenger RNA expression was measured by polymerase chain reaction (PCR). The response to 0.01 to 10 nM. dihydrotestosterone, 10 microM. flutamide and 1 to 1,000 ng./ml. keratinocyte growth factor was tested by [3H] thymidine assay. The difference in keratinocyte growth factor receptor and androgen receptor gene expression after treatment with and without keratinocyte growth factor and flutamide were determined by quantitative multiplex PCR and quantitated using densitometry analysis.
RESULTS: Immunocytochemical and electron microscopy characterization revealed typical epithelial differentiation. PCR showed keratinocyte growth factor receptor and androgen receptor expression in epithelial cultured cells but no keratinocyte growth factor expression. Epithelial cells showed a significant time and dose dependent stimulation of cell proliferation with keratinocyte growth factor and dihydrotestosterone (p <0.05). When combined with the anti-androgen flutamide the effect of 100 ng./ml. keratinocyte growth factor was significantly decreased (p <0.05). At 100 ng./ml. keratinocyte growth factor quantitative multiplex PCR revealed stimulated keratinocyte growth factor receptor and androgen receptor messenger RNA expression.
CONCLUSIONS: These results show that keratinocyte growth factor up-regulates the keratinocyte growth factor and androgen receptors in the absence of androgen. Thus, the androgen signaling pathway may be activated by growth factors such as keratinocyte growth factor in an androgen deficient environment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458116

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Androgen receptor-mediated inhibition of cutaneous wound healing.

Authors:  Gillian S Ashcroft; Stuart J Mills
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

Authors:  A H Palamakumbura; S R Vora; M A Nugent; K H Kirsch; G E Sonenshein; P C Trackman
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

3.  Immunoexpression of androgen receptor in the nontumorous pituitary and in adenomas.

Authors:  Bernd W Scheithauer; Kalman Kovacs; Suzan Zorludemir; Ricardo V Lloyd; Seyda Erdogan; Jeffrey Slezak
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Controlled dual release of dihydrotestosterone and flutamide from polycaprolactone electrospun scaffolds accelerate burn wound healing.

Authors:  Huaikai Shi; Kevin H-Y Tsai; Duncan Ma; Xiaosuo Wang; Reena Desai; Roxanne J Parungao; Nicholas J Hunt; Yuen Yee Cheng; Hao Zhang; Ye Xu; Ulla Simanainen; Qian Tan; Mark S Cooper; David J Handelsman; Peter K Maitz; Yiwei Wang
Journal:  FASEB J       Date:  2022-05       Impact factor: 5.834

5.  Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.

Authors:  Sanaz Memarzadeh; Li Xin; David J Mulholland; Alka Mansukhani; Hong Wu; Michael A Teitell; Owen N Witte
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.